Bachem Holding AG

Swiss Stock Exchange:BANB.SW

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Chemicals & Advanced Materials

🔬 Clinical Trials

🌿 Fertilizers

Location

Switzerland

Market Cap

USD 5.46 B

Share Price

USD 72.14

Avg Daily Volume

141,421

Change (1 day)

-0.89%

Change (1 year)

-18.27%

Change (YTD)

12.68%

Bachem Holding AG Shareholders' Equity for the year ending December 31, 2024: USD 1.53 B

Bachem Holding AG Shareholders' Equity is USD 1.53 B for the year ending December 31, 2024, a -2.34% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Bachem Holding AG Shareholders' Equity for the year ending December 31, 2023 was USD 1.57 B, a 24.00% change year over year.
Bachem Holding AG Shareholders' Equity for the year ending December 31, 2022 was USD 1.26 B, a 2.94% change year over year.
Bachem Holding AG Shareholders' Equity for the year ending December 31, 2021 was USD 1.23 B, a 128.66% change year over year.
Bachem Holding AG Shareholders' Equity for the year ending December 31, 2020 was USD 537.37 M, a 16.24% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Shareholders' Equity	Cash and Short-Term Investments	Receivables	Inventory

Swiss Stock Exchange: BANB.SW

Bachem Holding AG

CEO	Mr. Thomas Meier
IPO Date	July 17, 1998
Location	Switzerland
Headquarters	Hauptstrasse 144
Employees	2,207
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Chemicals & Advanced Materials 🔬 Clinical Trials 🌿 Fertilizers

Description

Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.